Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Registrati

Quotazioni in diretta

AURA Aura Biosciences Inc

9,15

-0,32 (-3,38%)

19 Nov 2024 - Chiuso

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

The sale reported represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.

Date of Notice

10/16/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Amy Elazzouzi, as Attorney-in-Fact

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Aura Biosciences (NASDAQ:AURA)
Storico
Da Ott 2024 a Nov 2024

Clicca qui per i Grafici di Aura Biosciences

Grafico Azioni Aura Biosciences (NASDAQ:AURA)
Storico
Da Nov 2023 a Nov 2024

Clicca qui per i Grafici di Aura Biosciences

Notizie Aura Biosciences Inc - AURA

Form 4 - Statement of changes in beneficial ownership of securities
Martedì 19 Novembre 2024 (3 ore fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Martedì 19 Novembre 2024 (5 ore fa) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Giovedì 14 Novembre 2024 (4 giorni fa) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Martedì 12 Novembre 2024 (6 giorni fa) • Edgar (US Regulatory)

Form 8-K - Current report
Martedì 12 Novembre 2024 (6 giorni fa) • Edgar (US Regulatory)

Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights
Martedì 12 Novembre 2024 (6 giorni fa) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Venerdì 8 Novembre 2024 (1 settimana fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercoledì 30 Ottobre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercoledì 30 Ottobre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mercoledì 30 Ottobre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 30 Ottobre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 30 Ottobre 2024 (3 settimane fa) • Edgar (US Regulatory)

Più Aura Biosciences Inc Articoli Notizie

Intesa Sanpaolo

ST Microelectronics

Banca Monte Dei Paschi D...

Mediobanca Banca di Cred...

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea